Background: CoronaVac (formerly PiCoVacc) is a formalin-inactivated and alum-adjuvanted candidate vaccine. Results from animal studies showed “partial or complete protection in macaques” exposed to SARS-CoV-2, according to a paper published by researchers in the journal Science.   Study Design: A Phase 1/2 trial enroll...

Chinese company Sinovac is developing a vaccine based on inactivated Covid-19 particles. The vaccine has shown a promising safety profile in the early stages of testing and is now moving into Phase 3 trials in Brazil involving 9,000 volunteers. Already Phase 3 trials for Sinovac's CoronaVac began last week in Indonesia involving...

There is an assertion that the Sinovac vaccine uses the "outdated" technology of inactivated whole viruses, and that such "next generation" technologies as mRNA vaccines (NIH/Moderna) and live adenovirus vaccines into which Covid genes are introduced (Oxford/Astra Zeneca) are preferable. There is no scientific basis for this...

An effective vaccine against SARS-CoV-2 will save countless lives in Bangladesh and around the world. If the Phase III trial of the Sinovac vaccine in Bangladesh demonstrates the vaccine to be safe and protective, Sinovac has agreed to provide over 110,000 free vaccine doses for the nation. And more importantly, Sinovac has...

The Bangladesh Medical Research Council or BMRC approved the phase 3 trial of Sinovac's vaccine candidate, known as CoronaVac.   But due to the novelty of the process, health authorities are awaiting approval from the government's top brass before flagging off the trials.   The International Centre for...